510(k) Report

510(k) · Cleared

Recalled · Class II · 2023

IQ 20 Series Analyzer, IQ 200 Series System, Nad IQ Lamina Cradle

K093861510(k) SpecialCleared Feb 5, 201051-day reviewClass II21 CFR 864.5200Recalls 4

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Iris International, Inc. · LKM Counter, Urine Particle

Cleared on Feb 5, 2010 after a 51-day review. The FDA summary names its predicate without a number. 3 later devices descend from it. It has been recalled 4 times.

Decided
Feb 5, 2010
Review
51 days
Class
Class II
Product code
LKM
Recalls
4
Predicates
0

3 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2024: 1 descendant cleared2021: 1 descendant cleared2025: 1 descendant cleared2010201520202025
  1. This deviceK093861 IQ 20 Series Analyzer, IQ 200 Series System, Nad IQ Lamina CradleIris International, Inc. · 2010
  2. Descendant · cites it directly · 1 of its ownK210127 iQ200 System, iChemVELOCITY Automated Urine Chemistry SystemBeckman Coulter, Inc. · 2021 · Recalled
  3. Descendant · cites it directly · 0 of its ownK252580 iQ200 SeriesBeckman Coulter, Inc. · 2025 · Recalled
  4. Descendant · cites it directly · 0 of its ownK232416 AUTION EYE AI-4510 Urine Particle Analysis SystemArkray, Inc. · 2024

Most influential descendants

Showing 3 of 3 · See all
  • K210127iQ200 System, iChemVELOCITY Automated Urine Chemistry SystemBeckman Coulter, Inc. · 2021 · cites it directly1descendant
  • K252580iQ200 SeriesBeckman Coulter, Inc. · 2025 · cites it directly0descendants
  • K232416AUTION EYE AI-4510 Urine Particle Analysis SystemArkray, Inc. · 2024 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K093861IQ 20 Series Analyzer, IQ 200 Series System, Nad IQ Lamina CradleIris International, Inc.2010—
+1K210127iQ200 System, iChemVELOCITY Automated Urine Chemistry SystemBeckman Coulter, Inc.20216
+1K252580iQ200 SeriesBeckman Coulter, Inc.20252
+1K232416AUTION EYE AI-4510 Urine Particle Analysis SystemArkray, Inc.2024—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202110
202410
202510
FIG. 1 — Lineage of K093861, 2010–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LKM? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LKM device

  1. #1 K252580 iQ200 Seriesscore 9.5 · 6 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (5)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—The Yellow IRIS Urinalysis Workstation with CHEMSTRIP Reader
Named without a submission number
—
*—IRIS Flow Microscope
Named without a submission number
—
*—900UDx Urine Pathology System
Named without a submission number
—
*—939UDx Urine Pathology System
Named without a submission number
—
*—Sysmex UF-100
Named without a submission number
—

What descends from it? (3)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K210127iQ200 System, iChemVELOCITY Automated Urine Chemistry SystemBeckman Coulter, Inc.20211
K252580iQ200 SeriesBeckman Coulter, Inc.20250
K232416AUTION EYE AI-4510 Urine Particle Analysis SystemArkray, Inc.20240

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Apr 5, 2023Class IIZ-1597-2023Under Investigation by firmBeckman Coulter has become aware of an intermittent issue in which the optional flag "Previous Sample Had Sperm" was enabled but not displayed so that a carryover event could have been investigated.
Apr 5, 2023Class IIZ-1599-2023Under Investigation by firmBeckman Coulter has become aware of an intermittent issue in which the optional flag "Previous Sample Had Sperm" was enabled but not displayed so that a carryover event could have been investigated.
Apr 5, 2023Class IIZ-1596-2023Under Investigation by firmBeckman Coulter has become aware of an intermittent issue in which the optional flag Previous Sample Had Sperm was enabled but not displayed so that a carryover event could have been investigated.
Apr 5, 2023Class IIZ-1598-2023Under Investigation by firmBeckman Coulter has become aware of an intermittent issue in which the optional flag "Previous Sample Had Sperm" was enabled but not displayed so that a carryover event could have been investigated.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K210127 (Beckman Coulter, Inc., 2021) has gone furthest, with 1 descendant of its own.

How does its category compare?

All LKM devices

LKM Counter, Urine Particle: FDA decisions, review times, recalls and adverse event reports over 20 years. 2010, this device’s year, is highlighted.

FDA decisions per year · LKM

1in 2025

2007: 12008: 12009: 12010: 12018: 12020: 12021: 12024: 12025: 1
2007high 1 (2007) · low 0 (2011)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LKM

Too few LKM 510(k)s in any year since 2007 to give a median.

Recalls per year · LKM

4in 2023

2013: 12019: 12023: 4
2007high 4 (2023) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LKM

1in 2021

2013: 32014: 12016: 32017: 12019: 22020: 22021: 1
2007high 3 (2013) · low 0 (2007)2025

MAUDE reports naming product code LKM, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20071—00
20081—00
20091—00
20101—00
20110—00
20120—00
20130—13
20140—01
20150—00
20160—03
20170—01
20181—00
20190—12
20201—02
20211—01
20220—00
20230—40
20241—00
20251—00
20260—0—

What is it indicated for?

The iQ 200 System is intended for analysis of urine chemistry, specific gravity, and formed sediment elements, which constitutes typical routine urinalysis. Urinalysis is ordered by physicians as a screening procedure for detection of possible abnormal metabolic or systemic disease, indicated by chemical composition of urine, and of potential renal or urinary tract disease or dysfunction, indicated by urine concentration and by the nature and…

Read the full statement (199 words)

The iQ 200 System is intended for analysis of urine chemistry, specific gravity, and formed sediment elements, which constitutes typical routine urinalysis.

Urinalysis is ordered by physicians as a screening procedure for detection of possible abnormal metabolic or systemic disease, indicated by chemical composition of urine, and of potential renal or urinary tract disease or dysfunction, indicated by urine concentration and by the nature and distribution of urinary formed elements. Urine profile testing is commonly employed in the initial clinical evaluation of patients admitted for hospital care or undergoing physical examinations.

Routine urinalysis is also indicated in diagnosis of patients with possible renal or urinary tract infection, carcinoma, or other injury, as well as for monitoring the status and effectiveness of drug, radiation, or dietary therapy, and of post-surgical or post-therapeutic recovery.

The information produced by the iQ 200 System concerning the composition of patient urines is ordered at the discretion of the physician, and is part of a larger body of laboratory and other test results available to assist the physician in health assessments or differential diagnoses. Routine urinalysis findings are always subject to judgment and interpretation by physicians relative to the patient's overall clinical presentation and history.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K093861: IQ 20 Series Analyzer, IQ 200 Series System, Nad IQ Lamina Cradle.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K093861

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026